Telix half-year revenue increases 22 per cent to 477 million dollars
August 20, 2026 | 14:51
Radiopharmaceutical manufacturer Telix Pharmaceuticals reported 477 million dollars in half-year group revenue on 20 August 2026, boosting gross margin to 55 per cent.
Latest News
Mobile Version